1.
Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry
by Johansson, Bente B
Diabetologia, 2016-12-02, Vol.60 (4), p.625-635
2.
New insights into the role of HNF-1β in kidney (patho)physiology
by Ferrè, Silvia
Pediatric nephrology (Berlin, West), 2018-07-01, Vol.34 (8), p.1325-1335
3.
A mitotic transcriptional switch in polycystic kidney disease
by Pontoglio, Marco
Nature medicine, 2010-01, Vol.16 (1), p.106-110
4.
Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors
by Fendler, Wojciech
Diabetologia, 2016-04-08, Vol.59 (7), p.1463-1473
5.
A Review of Functional Characterization of Single Amino Acid Change Mutations in HNF Transcription Factors in MODY Pathogenesis
by Çubuk, Hasan
The Protein Journal, 2021-05-05, Vol.40 (3), p.348-360
6.
HNF1B-associated clinical phenotypes: the kidney and beyond
by Bockenhauer, Detlef
Pediatric Nephrology, 2015-07-08, Vol.31 (5), p.707-714
7.
Variation in Maturity-Onset Diabetes of the Young Genes Influence Response to Interventions for Diabetes Prevention
by Billings, Liana K
The journal of clinical endocrinology and metabolism, 2017-08, Vol.102 (8), p.2678-2689
8.
HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)
by Lopes-Coelho, Filipa
Tumor biology, 2015-10-31, Vol.37 (4), p.4813-4829
9.
HNF1B nephropathy has a slow-progressive phenotype in childhood—with the exception of very early onset cases: results of the German Multicenter HNF1B Childhood Registry
by Okorn, Christine
Pediatric nephrology (Berlin, West), 2019-01-21, Vol.34 (6), p.1065-1075
10.
HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort
by Thomas, Rosemary
Pediatric nephrology (Berlin, West), 2011-06-01, Vol.26 (6), p.897-903
11.
Expanded Clinical Spectrum in Hepatocyte Nuclear Factor 1B-Maturity-Onset Diabetes of the Young
by Raile, Klemens
The journal of clinical endocrinology and metabolism, 2009-07, Vol.94 (7), p.2658-2664
12.
A case of a novel mutation in HNF1β -related maturity-onset diabetes of the young type 5 with diabetic kidney disease complication in a Chinese family
by Wang, Yiting
Journal of diabetes and its complications, 2016, Vol.31 (7), p.1243-1246
13.
Early Development of Hyperparathyroidism Due to Loss of PTH Transcriptional Repression in Patients With HNF1β Mutations?
by Ferrè, Silvia
The journal of clinical endocrinology and metabolism, 2013-10, Vol.98 (10), p.4089-4096
14.
A genetic link between type 2 diabetes and prostate cancer
by Frayling, T. M
Diabetologia, 2008-08-12, Vol.51 (10), p.1757-1760
15.
Biliary Anomalies in Patients With HNF1B Diabetes
by Kettunen, Jarno L T
The journal of clinical endocrinology and metabolism, 2017-06, Vol.102 (6), p.2075-2082
16.
Minireview: Pharmacogenetics and Beyond: The Interaction of Therapeutic Response, β-Cell Physiology, and Genetics in Diabetes
by Hattersley, Andrew T
Endocrinology (Philadelphia), 2006-06, Vol.147 (6), p.2657-2663
17.
Towards a new point of view on the phenotype of patients with a 17q12 microdeletion syndrome
by Laffargue, Fanny
Archives of disease in childhood, 2015-03, Vol.100 (3), p.259-264
18.
Hypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review
by van der Made, Cas I
American journal of nephrology, 2015-09, Vol.42 (1), p.85-90
19.
The Role of Tumor Necrosis Factor Alpha in Regulating the Expression of Tamm-Horsfall Protein (Uromodulin) in Thick Ascending Limbs during Kidney Injury
by Heitmeier, Monique
American journal of nephrology, 2014-12, Vol.40 (5), p.458-467
20.
HNF1B alterations associated with congenital anomalies of the kidney and urinary tract
by Nakayama, Makiko
Pediatric nephrology (Berlin, West), 2010-02-13, Vol.25 (6), p.1073-1079
